{{Rsnum
|rsid=3750117
|Chromosome=7
|position=33021334
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=NT5C3A
|Gene_s=NT5C3A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.2 | 32.2 | 57.6
| HCB | 20.5 | 54.5 | 25.0
| JPT | 25.6 | 44.2 | 30.2
| YRI | 3.2 | 21.0 | 75.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.5 | 54.5 | 25.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=25000516
|Title=NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia
}}

{{on chip | HumanOmni1Quad}}